Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Pancreatic Neoplasms × Decitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 30 Myelodysplastic Syndromes 8 Recurrence 6 Lymphoma, Large B-Cell, Diffuse 4 Hodgkin Disease 4 Leukemia, Myelomonocytic, Chronic 2 Wilms Tumor 1 TP53 1 Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden 1 Primary Malignant Neoplasm of Ovary 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Peripheral Blood Stem Cell Transplantation 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Neoplasms 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Malignant Solid Tumor 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Extranodal NK-T-Cell 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid 1 Leukemia 1 Hematopoietic System--Cancer 1 Graft vs Host Disease 1 Extranodal Extension 1 Esophageal Squamous Cell Carcinoma 1 Carcinoma, Renal Cell 1

Interventions

Gemcitabine 63 Fluorouracil 22 130-nm albumin-bound paclitaxel 19 Oxaliplatin 18 Leucovorin 13 Capecitabine 13 S 1 (combination) 12 Albumin-Bound Paclitaxel 12 Taxes 9 Radiosurgery 9 folfirinox 8 Irinotecan 8 Radiotherapy 6 Cisplatin 6 pembrolizumab 5 Pancreaticoduodenectomy 5 Drug Therapy 5 irinotecan sucrosofate 4 apatinib 4 Radiofrequency Ablation 4 Paclitaxel 4 Injections 4 Blood Specimen Collection 4 Biopsy 4 tislelizumab 3 rubitecan 3 Stents 3 Sorafenib 3 Radiation 3 Nivolumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02685228 2016-02-18

SLOWDOSE001

The First Hospital of Jilin University

Phase NA Unknown

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡